Metastatic/Recurrent Cervical Cancer
1 clinical trials · Condition
◉ Watch Metastatic/Recurrent Cervical Cancer
| Record | Firm | Date |
|---|---|---|
| Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer (NCT02164461) | Advaxis, Inc. | 2015-03-04 |
Track Metastatic/Recurrent Cervical Cancer automatically
Every clearance here is in the API, with alerts when new ones post.